市场调查报告书
商品编码
1625209
2030 年异丙醇市场预测:按类型、形状、分销管道、应用、最终用户和地区进行的全球分析Isopropyl Alcohol Market Forecasts to 2030 - Global Analysis By Type, Form, Distribution Channel, Application, End User and By Geography |
根据Stratistics MRC的数据,2024年全球异丙醇市场规模为33亿美元,预计在预测期内将以9.8%的复合年增长率成长,并在2030年达到59亿美元。
异丙醇,也称为异丙醇或外用酒精,是一种无色、易燃液体,具有强烈气味。由于其能够杀死细菌、病毒和真菌,通常用作消毒剂、防腐剂和溶剂。异丙醇广泛用于清洗剂、干洗手剂和医疗应用中,用于消毒表面和设备。它也用于化妆品和个人保健产品。其化学式为C3H8O,是工业及家庭用途的重要化合物。
据Astra Zeneca称,美国在药品销售方面占据主导地位,占全球药品销售量的 45% 以上和全球产量的 22%。 2024 年美国药品销售额预计将达到 6,330 亿美元。
对消毒剂和消毒剂的需求增加
由于异丙醇(IPA)广泛用于消毒剂和消毒剂,其需求量显着增加。它已成为清洗产品的重要成分,特别是在大流行之后,随着世界变得更加註重卫生和感染控制。由于其能够有效杀死细菌、病毒和其他病原体,因此广泛应用于医疗保健、製造和家用产品等多种行业。消毒剂和消毒剂需求的快速成长预计将持续下去,推动市场进一步走高。
严格的法规环境
市场上严格的法规环境可能会导致合规成本增加、产品核可延迟以及创新受到限制。公司在满足严格的安全和环境标准方面可能面临挑战,这可能会阻碍市场进入和扩张。此外,过度监管可能会导致供应链中断,减少异丙醇的可得性,并对依赖异丙醇进行製造和灭菌的行业产生负面影响。
扩大医药产业
製药业的扩张是市场成长的主要动力。 IPA 广泛用于药品製造中,清洗设备、消毒表面以及作为药物配方的溶剂。随着全球製药业的成长,特别是疫苗、药品和医疗设备产量的增加,对IPA的需求不断增加。 IPA 作为消毒剂和溶剂的有效性在维持製药设施的清洁和品管方面发挥着重要作用。
原物料价格不稳定
市场上原物料价格的波动会极大地影响生产成本并导致消费者的价格不稳定。由于丙烯等原料成本的波动影响整体定价策略,製造商可能难以维持利润率。这种不可预测性还可能导致供不应求和库存过剩,扰乱生产计划,并使企业难以进行长期规划。
COVID-19大流行显着增加了对异丙醇的需求,异丙醇广泛用于消毒剂和消毒剂。需求激增导致供不应求和价格上涨。然而,劳动力短缺和原材料供应链中断等生产挑战影响了製造商满足需求的能力。儘管大流行后市场正在趋于稳定,但对供应链和价格波动的挥之不去的影响仍然令人担忧。
预计液体部分在预测期内将是最大的
由于液体领域在清洗、消毒和工业应用方面的高效性,预计在预测期内将占据最大的市场占有率。液体异丙醇因其易于使用、快速蒸发和多功能性而成为医疗保健、製药和製造等多种行业的首选。异丙醇有多种浓度可供选择,其中 70% 和 99% 的溶液最常用于消毒和清洗应用。
预计医疗保健产业在预测期内复合年增长率最高
预计医疗保健产业在预测期内的复合年增长率最高。广泛用于医疗设备消毒、手部消毒、注射和手术前清洗皮肤。 70%的浓度对于杀死细菌、病毒和真菌特别有效。其快速蒸发和强大的防腐性能使其在医院和诊所等医疗机构中至关重要,可确保无菌环境并降低污染风险。
预计北美地区在预测期内将占据最大的市场占有率。消毒剂使用的增加,特别是在 COVID-19 大流行期间,显着促进了市场成长。该地区的主要企业专注于生产高品质异丙醇,以满足严格的监管标准。此外,对消毒剂和清洗剂的需求不断增长,进一步提振了市场,该地区在全球消费量中保持主导地位。
预计亚太地区在预测期内将实现最高成长率。异丙醇在医疗保健领域的需求不断增加,因为它被用作消毒剂和防腐剂,特别是在大流行期间和之后。在印度、中国和日本等国家尤其如此。此外,印度、中国和东南亚国家等国家的快速工业化正在推动汽车、建筑和纺织等製造过程中使用异丙醇的行业对异丙醇的需求。
According to Stratistics MRC, the Global Isopropyl Alcohol Market is accounted for $3.3 billion in 2024 and is expected to reach $5.9 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Isopropyl alcohol, also known as isopropanol or rubbing alcohol, is a colorless, flammable liquid with a strong odor. It is commonly used as a disinfectant, antiseptic, and solvent due to its ability to kill bacteria, viruses, and fungi. Isopropyl alcohol is widely employed in cleaning products, hand sanitizers, and medical applications for sterilizing surfaces and equipment. It can also be used in cosmetics and personal care products. With a chemical formula of C3H8O, it is an important compound in both industrial and household settings.
According to AstraZeneca, the United States dominates pharmaceutical sales with a share of over 45% of global pharmaceutical sales and 22% of global production. The projected pharmaceutical sales for the United States in 2024 are expected to be USD 633 billion.
Increasing demand for disinfectants and sanitizers
The demand for Isopropyl Alcohol (IPA) has experienced significant growth due to its widespread use in disinfectants and sanitizers. As global awareness of hygiene and infection control rises, especially post-pandemic, it has become a crucial ingredient in cleaning products. Its effectiveness in killing bacteria, viruses, and other pathogens drives its use across various industries, including healthcare, manufacturing, and household products. This surge in demand for sanitizers and disinfectants is expected to continue, further boosting the market.
Strict regulatory environment
A strict regulatory environment in the market can lead to increased compliance costs, delays in product approvals, and limited innovation. Companies may face challenges in meeting stringent safety and environmental standards, which can hinder market entry and expansion. Additionally, excessive regulations can create supply chain disruptions and reduce the availability of isopropyl alcohol, negatively impacting industries that rely on it for manufacturing and sanitization purposes.
Expanding pharmaceutical industry
The expanding pharmaceutical industry is a key driver of growth in the market. IPA is widely used in pharmaceutical manufacturing for cleaning equipment, sterilizing surfaces, and as a solvent in drug formulations. As the global pharmaceutical sector grows, particularly with the rise in production of vaccines, medicines, and medical devices, the demand for IPA continues to increase. Its effectiveness as a disinfectant and solvent ensures its vital role in maintaining cleanliness and quality control in pharmaceutical facilities.
Volatile raw material prices
Volatile raw material prices in the market can significantly impact production costs, leading to price instability for consumers. Manufacturers may struggle to maintain profit margins, as fluctuating costs of feedstocks like propylene affect overall pricing strategies. This unpredictability can also result in supply shortages or overstocking, disrupting production schedules and making it difficult for companies to plan long-term, which may hinder market growth and investor confidence.
The COVID-19 pandemic significantly boosted the demand for isopropyl alcohol due to its widespread use in disinfectants and sanitizers. This surge in demand led to supply shortages and increased prices. However, production challenges, such as labor shortages and disruptions in raw material supply chains, affected manufacturers' ability to meet demand. Post-pandemic, the market is stabilizing, but lingering effects on supply chains and pricing volatility remain an ongoing concern.
The liquid segment is expected to be the largest during the forecast period
The liquid segment is expected to account for the largest market share during the projection period as it is highly effective for cleaning, disinfecting, and industrial applications. Liquid isopropyl alcohol is preferred due to its ease of use, fast evaporation, and versatility across various sectors, including healthcare, pharmaceuticals, and manufacturing. It is available in different concentrations, with 70% and 99% solutions being the most widely used for sanitization and cleaning purposes.
The healthcare segment is expected to have the highest CAGR during the forecast period
The healthcare segment is expected to have the highest CAGR during the extrapolated period. It is widely used for disinfecting medical equipment, sanitizing hands, and cleaning skin before injections or surgeries. The 70% concentration is especially effective in killing bacteria, viruses, and fungi. Its rapid evaporation and strong antiseptic properties make it indispensable in hospitals, clinics, and other healthcare facilities, ensuring a sterile environment and reducing the risk of contamination.
North America region is projected to account for the largest market share during the forecast period. The increasing use of sanitizers, especially during the COVID-19 pandemic, significantly boosted market growth. Key players in the region focus on manufacturing high-quality isopropyl alcohol to meet stringent regulatory standards. Additionally, the growing demand for disinfectants and cleaning products further propels the market, with the region maintaining a dominant share in global consumption.
Asia Pacific is expected to register the highest growth rate over the forecast period. The use of Isopropyl Alcohol as a disinfectant and antiseptic, especially during and post-pandemic, has led to increased demand in the healthcare sector. This is particularly true in countries like India, China, and Japan. Additionally, the rapid industrialization in countries like India, China, and Southeast Asian nations drives demand for IPA in sectors like automotive, construction, and textiles, where it is used in manufacturing processes.
Key players in the market
Some of the key players in Isopropyl Alcohol market include Mitsubishi Chemical Corporation, Huntsman Corporation, SK Innovation, Covestro AG, Eastman Chemical Company, Nippon Shokubai Co., Ltd., Reliance Industries Limited, Mosaic Chemical Co. Ltd., Merck Group, Solvay S.A., ExxonMobil Corporation, Royal Dutch Shell Plc, Dow Inc., LG Chem Ltd., BASF SE and SABIC.
In November 2024, Solvay has reached an agreement to license its advanced hydrogen peroxide technology to North Huajin for use in its Panjin plant in Liaoning Province, China, which can produce 300,000 tonnes of propylene oxide per year and is scheduled to start production in 2026.
In October 2024, Covestro AG has entered into a pivotal Investment Agreement with ADNOC and its subsidiary, ADNOC International Germany Holding AG. As part of the deal, ADNOC International has launched a public takeover offer, proposing to acquire all outstanding Covestro shares at a price of €62.00 (US$68.75) per share, a premium of 54% over Covestro's unaffected share price before media coverage of the potential transaction.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.